Literature DB >> 4851942

Evidence for the presence of RNA in the purified virions of vaccinia virus.

G Roening, J A Holowczak.   

Abstract

Vaccinia virus, strain WR, was propagated in HeLa cells, L mouse fibroblats, or primary chicken embryo fibroblasts in the presence of [5- (3)H]uridine. Carefully purified virions were found to contain significant amounts of labeled trichloroacetic acid-precipitable material which was rendered acid soluble when digested with pancreatic RNase or hydrolyzed in alkali. Controlled degradation of virions with Nonidet P-40 and 2-mercaptoethanol demonstrated that 65 to 80% of the [5- (3)H]uridine-labeled molecules resided in the viral core. When the total nucleic acids were extracted from viral cores prepared from virions propagated in HeLa cells, 30 to 50% of the total incorporated [5- (3)H]uridine was found in RNA; in L mouse fibroblasts, 40 to 50%; in primary chicken embryo fibroblasts, 50 to 60%. The RNA molecules do not appear to be covalently linked to the viral DNA genome but sediment in sodium dodecyl sulfate-sucrose gradients as 8 to 10S species relative to ribosomal RNA.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4851942      PMCID: PMC355566     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Hybridization and sedimentation studies on "early" and "late" vaccinia messenger RNA.

Authors:  K I Oda; W K Joklik
Journal:  J Mol Biol       Date:  1967-08-14       Impact factor: 5.469

2.  Localization of nucleotide phosphohydrolase activity within vaccinia.

Authors:  P H Gold; S Dales
Journal:  Proc Natl Acad Sci U S A       Date:  1968-07       Impact factor: 11.205

3.  Regulation of the synthesis of nucleotide phosphohydrolase and neutral deoxyribonuclease: two activities present within purified vaccina virus.

Authors:  B G Pogo; S Dales
Journal:  Proc Natl Acad Sci U S A       Date:  1969-08       Impact factor: 11.205

4.  Poxvirus DNA-dependent RNA polymerase.

Authors:  J R Kates; B R McAuslan
Journal:  Proc Natl Acad Sci U S A       Date:  1967-07       Impact factor: 11.205

5.  RNA polymerase activity in purified infectious vaccinia virus.

Authors:  W Munyon; E Paoletti; J T Grace
Journal:  Proc Natl Acad Sci U S A       Date:  1967-12       Impact factor: 11.205

6.  Controlled degradation of vaccinia virions in vitro: an electron microscopic study.

Authors:  K B Easterbrook
Journal:  J Ultrastruct Res       Date:  1966-03

7.  The ribonuclease activity of crystallized pancreatic deoxyribonuclease.

Authors:  S B Zimmerman; D Sandeen
Journal:  Anal Biochem       Date:  1966-02       Impact factor: 3.365

8.  Studies on vaccinia virus DNA.

Authors:  I Sarov; Y Becker
Journal:  Virology       Date:  1967-11       Impact factor: 3.616

9.  Nucleotide phosphohydrolase in purified vaccinia virus.

Authors:  W Munyon; E Paoletti; J Ospina; J T Grace
Journal:  J Virol       Date:  1968-03       Impact factor: 5.103

10.  Two deoxyribonuclease activities within purified vaccinia virus.

Authors:  B G Pogo; S Dales
Journal:  Proc Natl Acad Sci U S A       Date:  1969-07       Impact factor: 11.205

View more
  4 in total

1.  Human and primate poxviruses: I. Growth characteristics of cytolytic and tumor variants.

Authors:  M R Sheek; A L Chapman; H A Wenner
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

2.  Targeting of a multicomponent transcription apparatus into assembling vaccinia virus particles requires RAP94, an RNA polymerase-associated protein.

Authors:  Y Zhang; B Y Ahn; B Moss
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

3.  Characterization of supercoiled nucleoprotein complexes released from detergent-treated vaccinia virions.

Authors:  M J Soloski; J A Holowczak
Journal:  J Virol       Date:  1981-02       Impact factor: 5.103

4.  Polyamines in vaccinia virions and polypeptides released from viral cores by acid extraction.

Authors:  W Lanzer; J A Holowczak
Journal:  J Virol       Date:  1975-11       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.